Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Seizures × Vigabatrin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 3 Seizures 1 Neoplasms 1 Epilepsy 1

Interventions

Levetiracetam 6 perampanel 2 Tranexamic Acid 2 ziprasidone 1 Zolpidem 1 Warfarin 1 Vigabatrin 1 Vecuronium Bromide 1 Vancomycin 1 Tobramycin 1 Standard of Care 1 Spironolactone 1 Sodium Chloride 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Remifentanil 1 Propofol 1 Pregabalin 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Nafcillin 1 Molindone 1 Methylprednisolone 1 Magnesium Sulfate 1 Lurasidone Hydrochloride 1 Labetalol 1 Haloperidol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01266291 2017-07-12

STARS

University of Pennsylvania

Phase 4 Terminated

1 enrolled 8 charts

Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡